Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML)
Clinical trial NCT03315039 · COMPLETED
Trial details
- NCT number
- NCT03315039
- Sponsor
- Moleculin Biotech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-28
- Primary completion
- 2020-01-14
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.